Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Recombinant human antibody directed against misfolded human superoxide dismutase 1

EU orphan designation number: EU/3/17/1894   
Active ingredient: Recombinant human antibody directed against misfolded human superoxide dismutase 1
Indication: Treatment of amyotrophic lateral sclerosis
Sponsor: Granzer Regulatory Consulting & Services
Kistlerhofstrasse 172c, Munich 81379, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/07/2017 Orphan designation EMA/OD/030/17 (2017)5158 of 17/07/2017
8/03/2019 Transfer of orphan designation EMA/OD/0000004025 (2019)1943 of 6/03/2019